Xylem (NYSE:XYL) Releases FY 2026 Earnings Guidance

Xylem (NYSE:XYL) issued an update on its FY 2026 earnings guidance on Tuesday. The company provided earnings per share guidance of 5.550-5.700 for the period, compared to the consensus earnings per share estimate of 5.530. The company issued revenue guidance of $9.2 billion-$9.2 billion, compared to the consensus revenue estimate of $9.2 billion.

Analysts Set New Price Targets

A number of brokerages have issued reports on XYL. Stifel Nicolaus cut their price objective on shares of Xylem from $159.00 to $157.00 and set a “buy” rating for the company in a report on Monday, July 20th. Oppenheimer lowered their target price on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a report on Wednesday, April 29th. Royal Bank Of Canada upped their target price on shares of Xylem from $157.00 to $159.00 and gave the stock an “outperform” rating in a research report on Thursday, July 16th. Barclays cut their target price on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a research note on Wednesday, April 29th. Finally, Citigroup reduced their price target on shares of Xylem from $174.00 to $168.00 and set a “buy” rating on the stock in a report on Wednesday, April 29th. Eight analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $153.15.

Xylem Trading Up 0.4%

Shares of NYSE XYL opened at $120.20 on Tuesday. The business’s 50 day moving average is $114.27 and its two-hundred day moving average is $122.55. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.46 and a quick ratio of 1.10. Xylem has a 1-year low of $105.29 and a 1-year high of $154.27. The stock has a market capitalization of $28.57 billion, a P/E ratio of 29.90, a PEG ratio of 1.70 and a beta of 1.03.

Xylem (NYSE:XYL) last issued its quarterly earnings data on Tuesday, July 28th. The industrial products company reported $1.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.34 by $0.12. The business had revenue of $2.34 billion for the quarter, compared to the consensus estimate of $2.34 billion. Xylem had a return on equity of 11.26% and a net margin of 10.79%.Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. As a group, research analysts expect that Xylem will post 5.52 EPS for the current year.

Xylem Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were issued a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a yield of 1.4%. The ex-dividend date was Thursday, May 28th. Xylem’s dividend payout ratio is presently 42.79%.

Insiders Place Their Bets

In other Xylem news, CAO Geri-Michelle Mcshane sold 4,269 shares of Xylem stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total transaction of $501,436.74. Following the completion of the transaction, the chief accounting officer directly owned 3,605 shares of the company’s stock, valued at $423,443.30. The trade was a 54.22% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jerome A. Peribere acquired 1,210 shares of the business’s stock in a transaction on Monday, May 4th. The shares were purchased at an average price of $116.61 per share, for a total transaction of $141,098.10. Following the transaction, the director directly owned 27,209 shares of the company’s stock, valued at approximately $3,172,841.49. The trade was a 4.65% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.32% of the stock is owned by company insiders.

Hedge Funds Weigh In On Xylem

Hedge funds have recently added to or reduced their stakes in the company. Wexford Capital LP purchased a new stake in Xylem in the 3rd quarter worth about $27,000. FWL Investment Management LLC bought a new stake in Xylem in the second quarter worth about $43,000. DV Equities LLC purchased a new position in shares of Xylem during the fourth quarter valued at approximately $46,000. Johnson Financial Group Inc. bought a new position in shares of Xylem during the third quarter valued at approximately $77,000. Finally, Zions Bancorporation National Association UT grew its stake in shares of Xylem by 36.1% during the fourth quarter. Zions Bancorporation National Association UT now owns 679 shares of the industrial products company’s stock valued at $92,000 after buying an additional 180 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.